Submental Fat Reduction with Injectables: Patient Selection and Injection Protocol
Submental fat reduction — the non-surgical treatment of the area beneath the chin that patients refer to as a 'double chin' — is the most evidence-supported, most precisely understood, and most widely practised injectable lipolytic application in aesthetic medicine. The zone has a defined fat compartment with reasonably predictable anatomy, a pharmaceutical-grade active agent with multiple Phase 3 RCTs behind it (deoxycholic acid, branded as Kybella/Belkyra), and a well-characterised safety profile built from extensive clinical experience.
Lipolytic Injectables: The Complete Practitioner's Guide
Injectable lipolytics — agents that chemically destroy subcutaneous fat cells — represent one of the most technically specific and outcome-dependent treatments in non-surgical aesthetic medicine. When patient selection is correct, the treatment zone is appropriate, the product and protocol are sound, and the patient's expectations are accurately set, injectable lipolytics produce permanent, visible, and highly valued results. When any of these elements is wrong, the risk of adverse outcomes — prolonged swelling, irregular contour, nerve injury — increases substantially.
